Abstract
Historically the diagnosis of celiac disease has relied upon clinical, serological, and histological evidence. In recent years the use of sensitive serological methods has meant an increase in the diagnosis of celiac disease. The heterogeneous nature of the disorder presents a challenge in the study and diagnosis of the disease with patients varying from subclinical or latent disease to patients with overt symptoms. Furthermore the related gluten-sensitive disease dermatitis herpetiformis, while distinct in some respects, shares clinical and serological features with celiac disease. Here we summarize current best practice for the diagnosis of celiac disease and briefly discuss newer approaches. The advent of next-generation assays for diagnosis and newer clinical protocols may result in more sensitive screening and ultimately the possible replacement of the intestinal biopsy as the gold standard for celiac disease diagnosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rashtak S, Murray JA (2009) Celiac disease in the elderly. Gastroenterol Clin North Am 38(3):433–446
Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, Shamir R, Troncone R, Giersiepen K, Branski D, Catassi C, Lelgeman M, Maki M, Ribes-Koninckx C, Ventura A, Zimmer KP (2012) European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 54(1):136–160
Kemppainen T, Uusitupa M, Janatuinen E, Jarvinen R, Julkunen R, Pikkarainen P (1995) Intakes of nutrients and nutritional status in coeliac patients. Scand J Gastroenterol 30(6):575–579
Hernandez L, Green PH (2006) Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep 8(5):383–389
Bolotin D, Petronic-Rosic V (2011) Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol 64(6):1017–1024, quiz 1025-1016
Sollid LM, Thorsby E (1993) HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 105(3):910–922
Hunt KA, Zhernakova A, Turner G et al (2008) Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 40(4):395–402
Tjon JM, van Bergen J, Koning F (2010) Celiac disease: how complicated can it get? Immunogenetics 62(10):641–651
Kneepkens CM, von Blomberg BM (2012) Clinical practice: coeliac disease. Eur J Pediatr 171(7):1011–1021
Ascher H, Hahn-Zoric M, Hanson LA, Kilander AF, Nilsson LA, Tlaskalova H (1996) Value of serologic markers for clinical diagnosis and population studies of coeliac disease. Scand J Gastroenterol 31(1):61–67
Centre for Clinical Practice at NICE (UK) (2009) Coeliac disease: recognition and assessment of coeliac disease. National Institute for Health and Clinical Excellence (UK), London, UK
Chorzelski TP, Beutner EH, Sulej J, Tchorzewska H, Jablonska S, Kumar V, Kapuscinska A (1984) IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol 111(4):395–402
Salmi TT, Collin P, Korponay-Szabo IR, Laurila K, Partanen J, Huhtala H, Kiraly R, Lorand L, Reunala T, Maki M, Kaukinen K (2006) Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut 55:1746–1753
Feighery C (1999) Fortnightly review: coeliac disease. Br Med J 319(7204):236–239
Lewis NR, Scott BB (2006) Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther 24(1):47–54
Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3(7):797–801
Brusco G, Muzi P, Ciccocioppo R, Biagi F, Cifone MG, Corazza GR (1999) Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression. Clin Exp Immunol 118(3):371–375
Fesus L, Piacentini M (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27(10):534–539
Koning F, Gilissen L, Wijmenga C (2005) Gluten: a two-edged sword. Immunopathogenesis of celiac disease. Springer Semin Immunopathol 27(2):217–232
Caputo I, Barone MV, Martucciello S, Lepretti M, Esposito C (2009) Tissue transglutaminase in celiac disease: role of autoantibodies. Amino Acids 36(4):693–699
Sollid LM, Molberg O, McAdam S, Lundin KE (1997) Autoantibodies in coeliac disease: tissue transglutaminase–guilt by association? Gut 41(6):851–852
Schuppan D, Hahn EG (2001) IgA anti-tissue transglutaminase: setting the stage for coeliac disease screening. Eur J Gastroenterol Hepatol 13(6):635–637
Nachman F, Sugai E, Vazquez H, Gonzalez A, Andrenacci P, Niveloni S, Mazure R, Smecuol E, Moreno ML, Hwang HJ, Sanchez MI, Maurino E, Bai JC (2011) Serological tests for celiac disease as indicators of long-term compliance with the gluten-free diet. Eur J Gastroenterol Hepatol 23(6):473–480
Amarri S, Alvisi P, De Giorgio R, Gelli MC, Cicola R, Tovoli F, Sassatelli R, Caio G, Volta U (2013) Antibodies to deamidated gliadin peptides: an accurate predictor of coeliac disease in infancy. J Clin Immunol 33(5):1027–1030
Bizzaro N, Tozzoli R, Villalta D, Fabris M, Tonutti E (2012) Cutting-edge issues in celiac disease and in gluten intolerance. Clin Rev Allergy Immunol 42(3):279–287
Bottaro G, Cataldo F, Rotolo N, Spina M, Corazza GR (1999) The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases. Am J Gastroenterol 94(3):691–696
Cataldo F, Lio D, Marino V, Picarelli A, Ventura A, Corazza GR (2000) IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue. Gut 47(3):366–369
van der Meer JB (1969) Granular deposits of immunoglobulins in the skin of patients with dermatitis herpetiformis. An immunofluorescent study. Br J Dermatol 81(7):493–503
Nakajima K (2012) Recent advances in dermatitis herpetiformis. Clin Dev Immunol 2012:914162
Borroni G, Biagi F, Ciocca O, Vassallo C, Carugno A, Cananzi R, Campanella J, Bianchi PI, Brazzelli V, Corazza GR (2013) IgA anti-epidermal transglutaminase autoantibodies: a sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients. J Eur Acad Dermatol Venereol 27(7):836–841
Green PH, Rostami K, Marsh MN (2005) Diagnosis of coeliac disease. Best Pract Res Clin Gastroenterol 19(3):389–400
Rodrigues AF, Jenkins HR (2008) Investigation and management of coeliac disease. Arch Dis Child 93(3):251–254
Walker-Smith JA, Guandalini S, Schmitz J, Shmerling D, Visakorpi J (1990) Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 65(8):909–911
Collin P, Kaukinen K, Vogelsang H et al (2005) Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 17(1):85–91
Vivas S, Ruiz de Morales JG, Riestra S et al (2009) Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol 15(38):4775–4780
Fernandez-Banares F, Alsina M, Modolell I et al (2012) Are positive serum-IgA-tissue-transglutaminase antibodies enough to diagnose coeliac disease without a small bowel biopsy? Post-test probability of coeliac disease. J Crohns Colitis 6(8):861–866
Carroccio A, Brusca I, Iacono G et al (2007) IgA anti-actin antibodies ELISA in coeliac disease: a multicentre study. Dig Liver Dis 39(9):818–823
Droste A, Sorg C, Hogger P (1999) Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family. Biochem Biophys Res Commun 256(1):110–113
Daly A, Walsh C, Feighery C, O’Shea U, Jackson J, Whelan A (2006) Serum levels of soluble CD163 correlate with the inflammatory process in coeliac disease. Aliment Pharmacol Ther 24(3):553–559
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Byrne, G., Feighery, C.F. (2015). Celiac Disease: Diagnosis. In: Ryan, A. (eds) Celiac Disease. Methods in Molecular Biology, vol 1326. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2839-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2839-2_2
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2838-5
Online ISBN: 978-1-4939-2839-2
eBook Packages: Springer Protocols